Intercontinental Wealth Advisors, LLC Genmab A/S Transaction History

Intercontinental Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$41.55 - $48.72 $655,908 - $769,093	-15,786 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$32.88 - $44.57 $13,809 - $18,719	420 Added 2.73%	15,786 $645,000
Q1 2021 May 14, 2021	BUY	$30.92 - $44.4 $45,483 - $65,312	1,471 Added 10.59%	15,366 $504,000
Q4 2020 Feb 19, 2021	BUY	$33.66 - $40.76 $467,705 - $566,360	13,895 New	13,895 $565,000

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Intercontinental Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Intercontinental Wealth Advisors, LLC with notifications on news.